Global Veterinary Biological Vaccines Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
188
Industry
Biopharmaceuticals
Regions
Global
Updated
February 2026

Report Overview


Report Overview
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system?s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly ?6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 551%.

The global Veterinary Biological Vaccines market size was estimated at USD 5442.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.90% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Veterinary Biological Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Veterinary Biological Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Veterinary Biological Vaccines market.
Global Veterinary Biological Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Yebio
DHN
WINSUN
Elanco
Virbac
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
Ringpu Biology
Jinyu Bio-technology
Jinhe Biotechnology
China Animal Husbandry Industry
Wuhan Keqian Biology
Pulike Biological Engineering
Chengdu Kanghua Biological Products

Market Segmentation (by Type)
Live Attenuated Vaccines
Inactivated Vaccines
Others

Market Segmentation (by Application)
Livestock
Swine
Chicken
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Veterinary Biological Vaccines Market
Overview of the regional outlook of the Veterinary Biological Vaccines Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Veterinary Biological Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Veterinary Biological Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Veterinary Biological Vaccines
    • 1.2 Key Market Segments
      • 1.2.1 Veterinary Biological Vaccines Segment by Type
      • 1.2.2 Veterinary Biological Vaccines Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Veterinary Biological Vaccines Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Veterinary Biological Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Veterinary Biological Vaccines Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Veterinary Biological Vaccines Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Veterinary Biological Vaccines Product Life Cycle
    • 3.3 Global Veterinary Biological Vaccines Sales by Manufacturers (2020-2025)
    • 3.4 Global Veterinary Biological Vaccines Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Veterinary Biological Vaccines Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Veterinary Biological Vaccines Market Competitive Situation and Trends
      • 3.8.1 Veterinary Biological Vaccines Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Veterinary Biological Vaccines Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Veterinary Biological Vaccines Industry Chain Analysis
    • 4.1 Veterinary Biological Vaccines Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Veterinary Biological Vaccines Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Veterinary Biological Vaccines Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy ? April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Veterinary Biological Vaccines Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Veterinary Biological Vaccines Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Veterinary Biological Vaccines Sales Market Share by Type (2020-2025)
    • 6.3 Global Veterinary Biological Vaccines Market Size by Type (2020-2025)
    • 6.4 Global Veterinary Biological Vaccines Price by Type (2020-2025)
  • 7 Veterinary Biological Vaccines Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Veterinary Biological Vaccines Market Sales by Application (2020-2025)
    • 7.3 Global Veterinary Biological Vaccines Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Veterinary Biological Vaccines Sales Growth Rate by Application (2020-2025)
  • 8 Veterinary Biological Vaccines Market Sales by Region
    • 8.1 Global Veterinary Biological Vaccines Sales by Region
      • 8.1.1 Global Veterinary Biological Vaccines Sales by Region
      • 8.1.2 Global Veterinary Biological Vaccines Sales Market Share by Region
    • 8.2 Global Veterinary Biological Vaccines Market Size by Region
      • 8.2.1 Global Veterinary Biological Vaccines Market Size by Region
      • 8.2.2 Global Veterinary Biological Vaccines Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Veterinary Biological Vaccines Sales by Country
      • 8.3.2 North America Veterinary Biological Vaccines Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Veterinary Biological Vaccines Sales by Country
      • 8.4.2 Europe Veterinary Biological Vaccines Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Veterinary Biological Vaccines Sales by Region
      • 8.5.2 Asia Pacific Veterinary Biological Vaccines Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Veterinary Biological Vaccines Sales by Country
      • 8.6.2 South America Veterinary Biological Vaccines Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Veterinary Biological Vaccines Sales by Region
      • 8.7.2 Middle East and Africa Veterinary Biological Vaccines Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Veterinary Biological Vaccines Market Production by Region
    • 9.1 Global Production of Veterinary Biological Vaccines by Region(2020-2025)
    • 9.2 Global Veterinary Biological Vaccines Revenue Market Share by Region (2020-2025)
    • 9.3 Global Veterinary Biological Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Veterinary Biological Vaccines Production
      • 9.4.1 North America Veterinary Biological Vaccines Production Growth Rate (2020-2025)
      • 9.4.2 North America Veterinary Biological Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Veterinary Biological Vaccines Production
      • 9.5.1 Europe Veterinary Biological Vaccines Production Growth Rate (2020-2025)
      • 9.5.2 Europe Veterinary Biological Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Veterinary Biological Vaccines Production (2020-2025)
      • 9.6.1 Japan Veterinary Biological Vaccines Production Growth Rate (2020-2025)
      • 9.6.2 Japan Veterinary Biological Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Veterinary Biological Vaccines Production (2020-2025)
      • 9.7.1 China Veterinary Biological Vaccines Production Growth Rate (2020-2025)
      • 9.7.2 China Veterinary Biological Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 Merck
      • 10.1.1 Merck Basic Information
      • 10.1.2 Merck Veterinary Biological Vaccines Product Overview
      • 10.1.3 Merck Veterinary Biological Vaccines Product Market Performance
      • 10.1.4 Merck Business Overview
      • 10.1.5 Merck SWOT Analysis
      • 10.1.6 Merck Recent Developments
    • 10.2 Zoetis
      • 10.2.1 Zoetis Basic Information
      • 10.2.2 Zoetis Veterinary Biological Vaccines Product Overview
      • 10.2.3 Zoetis Veterinary Biological Vaccines Product Market Performance
      • 10.2.4 Zoetis Business Overview
      • 10.2.5 Zoetis SWOT Analysis
      • 10.2.6 Zoetis Recent Developments
    • 10.3 Boehringer Ingelheim
      • 10.3.1 Boehringer Ingelheim Basic Information
      • 10.3.2 Boehringer Ingelheim Veterinary Biological Vaccines Product Overview
      • 10.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Product Market Performance
      • 10.3.4 Boehringer Ingelheim Business Overview
      • 10.3.5 Boehringer Ingelheim SWOT Analysis
      • 10.3.6 Boehringer Ingelheim Recent Developments
    • 10.4 Ceva
      • 10.4.1 Ceva Basic Information
      • 10.4.2 Ceva Veterinary Biological Vaccines Product Overview
      • 10.4.3 Ceva Veterinary Biological Vaccines Product Market Performance
      • 10.4.4 Ceva Business Overview
      • 10.4.5 Ceva Recent Developments
    • 10.5 CAHIC
      • 10.5.1 CAHIC Basic Information
      • 10.5.2 CAHIC Veterinary Biological Vaccines Product Overview
      • 10.5.3 CAHIC Veterinary Biological Vaccines Product Market Performance
      • 10.5.4 CAHIC Business Overview
      • 10.5.5 CAHIC Recent Developments
    • 10.6 HVRI
      • 10.6.1 HVRI Basic Information
      • 10.6.2 HVRI Veterinary Biological Vaccines Product Overview
      • 10.6.3 HVRI Veterinary Biological Vaccines Product Market Performance
      • 10.6.4 HVRI Business Overview
      • 10.6.5 HVRI Recent Developments
    • 10.7 Yebio
      • 10.7.1 Yebio Basic Information
      • 10.7.2 Yebio Veterinary Biological Vaccines Product Overview
      • 10.7.3 Yebio Veterinary Biological Vaccines Product Market Performance
      • 10.7.4 Yebio Business Overview
      • 10.7.5 Yebio Recent Developments
    • 10.8 DHN
      • 10.8.1 DHN Basic Information
      • 10.8.2 DHN Veterinary Biological Vaccines Product Overview
      • 10.8.3 DHN Veterinary Biological Vaccines Product Market Performance
      • 10.8.4 DHN Business Overview
      • 10.8.5 DHN Recent Developments
    • 10.9 WINSUN
      • 10.9.1 WINSUN Basic Information
      • 10.9.2 WINSUN Veterinary Biological Vaccines Product Overview
      • 10.9.3 WINSUN Veterinary Biological Vaccines Product Market Performance
      • 10.9.4 WINSUN Business Overview
      • 10.9.5 WINSUN Recent Developments
    • 10.10 Elanco
      • 10.10.1 Elanco Basic Information
      • 10.10.2 Elanco Veterinary Biological Vaccines Product Overview
      • 10.10.3 Elanco Veterinary Biological Vaccines Product Market Performance
      • 10.10.4 Elanco Business Overview
      • 10.10.5 Elanco Recent Developments
    • 10.11 Virbac
      • 10.11.1 Virbac Basic Information
      • 10.11.2 Virbac Veterinary Biological Vaccines Product Overview
      • 10.11.3 Virbac Veterinary Biological Vaccines Product Market Performance
      • 10.11.4 Virbac Business Overview
      • 10.11.5 Virbac Recent Developments
    • 10.12 CAVAC
      • 10.12.1 CAVAC Basic Information
      • 10.12.2 CAVAC Veterinary Biological Vaccines Product Overview
      • 10.12.3 CAVAC Veterinary Biological Vaccines Product Market Performance
      • 10.12.4 CAVAC Business Overview
      • 10.12.5 CAVAC Recent Developments
    • 10.13 Kyoto Biken Laboratories
      • 10.13.1 Kyoto Biken Laboratories Basic Information
      • 10.13.2 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Overview
      • 10.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Market Performance
      • 10.13.4 Kyoto Biken Laboratories Business Overview
      • 10.13.5 Kyoto Biken Laboratories Recent Developments
    • 10.14 FATRO
      • 10.14.1 FATRO Basic Information
      • 10.14.2 FATRO Veterinary Biological Vaccines Product Overview
      • 10.14.3 FATRO Veterinary Biological Vaccines Product Market Performance
      • 10.14.4 FATRO Business Overview
      • 10.14.5 FATRO Recent Developments
    • 10.15 Vaksindo
      • 10.15.1 Vaksindo Basic Information
      • 10.15.2 Vaksindo Veterinary Biological Vaccines Product Overview
      • 10.15.3 Vaksindo Veterinary Biological Vaccines Product Market Performance
      • 10.15.4 Vaksindo Business Overview
      • 10.15.5 Vaksindo Recent Developments
    • 10.16 Bio-Labs
      • 10.16.1 Bio-Labs Basic Information
      • 10.16.2 Bio-Labs Veterinary Biological Vaccines Product Overview
      • 10.16.3 Bio-Labs Veterinary Biological Vaccines Product Market Performance
      • 10.16.4 Bio-Labs Business Overview
      • 10.16.5 Bio-Labs Recent Developments
    • 10.17 Avimex Animal Health
      • 10.17.1 Avimex Animal Health Basic Information
      • 10.17.2 Avimex Animal Health Veterinary Biological Vaccines Product Overview
      • 10.17.3 Avimex Animal Health Veterinary Biological Vaccines Product Market Performance
      • 10.17.4 Avimex Animal Health Business Overview
      • 10.17.5 Avimex Animal Health Recent Developments
    • 10.18 MEVAC
      • 10.18.1 MEVAC Basic Information
      • 10.18.2 MEVAC Veterinary Biological Vaccines Product Overview
      • 10.18.3 MEVAC Veterinary Biological Vaccines Product Market Performance
      • 10.18.4 MEVAC Business Overview
      • 10.18.5 MEVAC Recent Developments
    • 10.19 Biovac
      • 10.19.1 Biovac Basic Information
      • 10.19.2 Biovac Veterinary Biological Vaccines Product Overview
      • 10.19.3 Biovac Veterinary Biological Vaccines Product Market Performance
      • 10.19.4 Biovac Business Overview
      • 10.19.5 Biovac Recent Developments
    • 10.20 Atafen
      • 10.20.1 Atafen Basic Information
      • 10.20.2 Atafen Veterinary Biological Vaccines Product Overview
      • 10.20.3 Atafen Veterinary Biological Vaccines Product Market Performance
      • 10.20.4 Atafen Business Overview
      • 10.20.5 Atafen Recent Developments
    • 10.21 Dyntec
      • 10.21.1 Dyntec Basic Information
      • 10.21.2 Dyntec Veterinary Biological Vaccines Product Overview
      • 10.21.3 Dyntec Veterinary Biological Vaccines Product Market Performance
      • 10.21.4 Dyntec Business Overview
      • 10.21.5 Dyntec Recent Developments
    • 10.22 Ringpu Biology
      • 10.22.1 Ringpu Biology Basic Information
      • 10.22.2 Ringpu Biology Veterinary Biological Vaccines Product Overview
      • 10.22.3 Ringpu Biology Veterinary Biological Vaccines Product Market Performance
      • 10.22.4 Ringpu Biology Business Overview
      • 10.22.5 Ringpu Biology Recent Developments
    • 10.23 Jinyu Bio-technology
      • 10.23.1 Jinyu Bio-technology Basic Information
      • 10.23.2 Jinyu Bio-technology Veterinary Biological Vaccines Product Overview
      • 10.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Product Market Performance
      • 10.23.4 Jinyu Bio-technology Business Overview
      • 10.23.5 Jinyu Bio-technology Recent Developments
    • 10.24 Jinhe Biotechnology
      • 10.24.1 Jinhe Biotechnology Basic Information
      • 10.24.2 Jinhe Biotechnology Veterinary Biological Vaccines Product Overview
      • 10.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Product Market Performance
      • 10.24.4 Jinhe Biotechnology Business Overview
      • 10.24.5 Jinhe Biotechnology Recent Developments
    • 10.25 China Animal Husbandry Industry
      • 10.25.1 China Animal Husbandry Industry Basic Information
      • 10.25.2 China Animal Husbandry Industry Veterinary Biological Vaccines Product Overview
      • 10.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Product Market Performance
      • 10.25.4 China Animal Husbandry Industry Business Overview
      • 10.25.5 China Animal Husbandry Industry Recent Developments
    • 10.26 Wuhan Keqian Biology
      • 10.26.1 Wuhan Keqian Biology Basic Information
      • 10.26.2 Wuhan Keqian Biology Veterinary Biological Vaccines Product Overview
      • 10.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Product Market Performance
      • 10.26.4 Wuhan Keqian Biology Business Overview
      • 10.26.5 Wuhan Keqian Biology Recent Developments
    • 10.27 Pulike Biological Engineering
      • 10.27.1 Pulike Biological Engineering Basic Information
      • 10.27.2 Pulike Biological Engineering Veterinary Biological Vaccines Product Overview
      • 10.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Product Market Performance
      • 10.27.4 Pulike Biological Engineering Business Overview
      • 10.27.5 Pulike Biological Engineering Recent Developments
    • 10.28 Chengdu Kanghua Biological Products
      • 10.28.1 Chengdu Kanghua Biological Products Basic Information
      • 10.28.2 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Overview
      • 10.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Market Performance
      • 10.28.4 Chengdu Kanghua Biological Products Business Overview
      • 10.28.5 Chengdu Kanghua Biological Products Recent Developments
  • 11 Veterinary Biological Vaccines Market Forecast by Region
    • 11.1 Global Veterinary Biological Vaccines Market Size Forecast
    • 11.2 Global Veterinary Biological Vaccines Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Veterinary Biological Vaccines Market Size Forecast by Country
      • 11.2.3 Asia Pacific Veterinary Biological Vaccines Market Size Forecast by Region
      • 11.2.4 South America Veterinary Biological Vaccines Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Veterinary Biological Vaccines by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Veterinary Biological Vaccines Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Veterinary Biological Vaccines by Type (2026-2035)
      • 12.1.2 Global Veterinary Biological Vaccines Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Veterinary Biological Vaccines by Type (2026-2035)
    • 12.2 Global Veterinary Biological Vaccines Market Forecast by Application (2026-2035)
      • 12.2.1 Global Veterinary Biological Vaccines Sales (K MT) Forecast by Application
      • 12.2.2 Global Veterinary Biological Vaccines Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.